Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01802437

An Adaptive Treatment Strategy for Adolescent Depression (PTAD)

Sponsor: University of Minnesota

Interventions Continue to Receive Initial Dose of Interpersonal Psychotherapy Fluoxetine Increased Dose of Interpersonal Psychotherapy

Updated 7 times since 2017 Last updated: Jul 10, 2019 Started: Nov 30, 2010 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Adolescent Depression, this trial is completed. The trial is conducted by University of Minnesota and has accumulated 7 data snapshots since 2010. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Nov 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Aug 2019 — Nov 2019 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Jun 2018 — Aug 2019 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States